Update on Antithrombotic Agents in Secondar y Stroke Prevention

Tatjana Rundek; Vanja Bašić-Kes; Sandra Morović; Vida Demarin

Update on Antithrombotic Agents in Secondar y Stroke Prevention

Tatjana Rundek, Vanja Bašić-Kes, Sandra Morović, Vida Demarin

Neurology

Research output: Contribution to journal › Review article › peer-review

Abstract

Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.

Original language	English (US)
Pages (from-to)	101-106
Number of pages	6
Journal	Acta Clinica Croatica
Volume	50
Issue number	1
State	Published - Dec 1 2011

Keywords

Anticoagulants
Platelet aggregation inhibitors
Prevention and control
Secondary prevention
Stroke
Therapeutic use

ASJC Scopus subject areas

Medicine(all)

Fingerprint Dive into the research topics of 'Update on Antithrombotic Agents in Secondar y Stroke Prevention'. Together they form a unique fingerprint.

Cite this

@article{2323b434c0c74165bc3296163dc1702d,

title = "Update on Antithrombotic Agents in Secondar y Stroke Prevention",

abstract = "Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.",

keywords = "Anticoagulants, Platelet aggregation inhibitors, Prevention and control, Secondary prevention, Stroke, Therapeutic use",

author = "Tatjana Rundek and Vanja Ba{\v s}i{\'c}-Kes and Sandra Morovi{\'c} and Vida Demarin",

year = "2011",

month = dec,

day = "1",

language = "English (US)",

volume = "50",

pages = "101--106",

journal = "Acta Clinica Croatica",

issn = "0353-9466",

publisher = "Klinicka Bolnica Sestre Milosrdnice",

number = "1",

}

TY - JOUR

T1 - Update on Antithrombotic Agents in Secondar y Stroke Prevention

AU - Rundek, Tatjana

AU - Bašić-Kes, Vanja

AU - Morović, Sandra

AU - Demarin, Vida

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.

AB - Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.

KW - Anticoagulants

KW - Platelet aggregation inhibitors

KW - Prevention and control

KW - Secondary prevention

KW - Stroke

KW - Therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=84855161173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855161173&partnerID=8YFLogxK

M3 - Review article

C2 - 22034789

AN - SCOPUS:84855161173

VL - 50

SP - 101

EP - 106

JO - Acta Clinica Croatica

JF - Acta Clinica Croatica

SN - 0353-9466

IS - 1

ER -

Update on Antithrombotic Agents in Secondar y Stroke Prevention

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Cite this